1. Home
  2. LTRX vs DERM Comparison

LTRX vs DERM Comparison

Compare LTRX & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lantronix Inc.

LTRX

Lantronix Inc.

HOLD

Current Price

$6.89

Market Cap

225.9M

ML Signal

HOLD

Logo Journey Medical Corporation

DERM

Journey Medical Corporation

HOLD

Current Price

$8.03

Market Cap

210.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LTRX
DERM
Founded
1989
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
225.9M
210.0M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
LTRX
DERM
Price
$6.89
$8.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$6.17
$12.67
AVG Volume (30 Days)
584.8K
129.3K
Earning Date
02-05-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$118,294,000.00
$59,399,000.00
Revenue This Year
$4.59
$17.48
Revenue Next Year
$12.82
$55.83
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.82
52 Week Low
$1.91
$3.54
52 Week High
$6.96
$9.40

Technical Indicators

Market Signals
Indicator
LTRX
DERM
Relative Strength Index (RSI) 72.98 53.99
Support Level $5.94 $7.15
Resistance Level $6.63 $8.40
Average True Range (ATR) 0.38 0.41
MACD 0.07 0.08
Stochastic Oscillator 98.07 72.03

Price Performance

Historical Comparison
LTRX
DERM

About LTRX Lantronix Inc.

Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Share on Social Networks: